• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

METTL14 介导的 m6A 修饰促进血管内皮细胞铁过载诱导的脂质过氧化损伤加重动脉粥样硬化的机制。

Mechanisms of METTL14-Mediated m6A Modification in Promoting Iron Overload-Induced Lipid Peroxidative Damage in Vascular Endothelial Cells to Aggravate Atherosclerosis.

机构信息

Department of Cerebrovascular Diseases, the Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Department of Neurosurgery, the Second Affiliated Hospital of Kunming Medical University, Kunming, China.

出版信息

J Biochem Mol Toxicol. 2024 Dec;38(12):e70066. doi: 10.1002/jbt.70066.

DOI:10.1002/jbt.70066
PMID:39588760
Abstract

Atherosclerosis (AS) is a chronic multifactorial disease with damage to vascular endothelial cells (VECs). This study sought to delve into the mechanism of methyltransferase-like 14 (METTL14) in iron overload-induced lipid peroxidative damage in AS. AS mouse model and cell model were established. Levels of METTL14/circRNA coded by the Arhgap12 (circARHGAP12)/Aspartate β-hydroxylase (ASPH) were determined. AS plaque area/lipid deposition/lipid metabolism in AS mice and iron overload in VECs were evaluated. N6-methyladenosine (m6A) level and METTL14 enrichment and human antigen R (HuR) in circARHGAP12 or ASPH were measured. The mRNA stability of circARHGAP12 or ASPH was analyzed. We observed that METTL14 was upregulated in AS mice. METTL14 downregulation reduced plaque area/lipid deposition/iron overload/peroxidative damage in AS mice. In cell models, METTL14 downregulation could VEC injury/iron overload/lipid peroxidative damage. Mechanically, METTL14 increased the stability and expression of circARHGAP12 through m6A modification, further stabilized ASPH mRNA, and promoted ASPH transcription by binding to HuR. Overexpression of circARHGAP12 or inhibition of ASPH averted the protective role of METTL14 downregulation against iron overload-induced peroxidative damage in AS. In conclusion, METTL14-mediated m6A modification upregulated circARHGAP12 and ASPH to aggravate overload-induced lipid peroxidative damage and facilitate AS progression.

摘要

动脉粥样硬化(AS)是一种慢性多因素疾病,会损伤血管内皮细胞(VECs)。本研究旨在深入探讨甲基转移酶样 14(METTL14)在 AS 中铁过载诱导的脂质过氧化损伤中的作用机制。建立了 AS 小鼠模型和细胞模型。测定 METTL14/由 Arhgap12(circARHGAP12)/天冬氨酸β-羟化酶(ASPH)编码的环状 RNA(circRNA)水平。评估 AS 小鼠 AS 斑块面积/脂质沉积/脂质代谢和 VEC 中铁过载情况。测量 N6-甲基腺苷(m6A)水平和 METTL14 富集以及 circARHGAP12 或 ASPH 中的 HuR。分析 circARHGAP12 或 ASPH 的 mRNA 稳定性。结果显示,AS 小鼠中 METTL14 上调。METTL14 下调可减少 AS 小鼠的斑块面积/脂质沉积/铁过载/过氧化损伤。在细胞模型中,METTL14 下调可减轻 VEC 损伤/铁过载/脂质过氧化损伤。机制上,METTL14 通过 m6A 修饰增加 circARHGAP12 的稳定性和表达,进一步稳定 ASPH mRNA,并通过与 HuR 结合促进 ASPH 转录。circARHGAP12 的过表达或 ASPH 的抑制可逆转 METTL14 下调对 AS 中铁过载诱导的过氧化损伤的保护作用。综上所述,METTL14 介导的 m6A 修饰上调 circARHGAP12 和 ASPH,加重铁过载诱导的脂质过氧化损伤,促进 AS 进展。

相似文献

1
Mechanisms of METTL14-Mediated m6A Modification in Promoting Iron Overload-Induced Lipid Peroxidative Damage in Vascular Endothelial Cells to Aggravate Atherosclerosis.METTL14 介导的 m6A 修饰促进血管内皮细胞铁过载诱导的脂质过氧化损伤加重动脉粥样硬化的机制。
J Biochem Mol Toxicol. 2024 Dec;38(12):e70066. doi: 10.1002/jbt.70066.
2
METTL3-mediated m6A modification enhances lncRNA H19 stability to promote endothelial cell inflammation and pyroptosis to aggravate atherosclerosis.METTL3 介导的 m6A 修饰增强 lncRNA H19 的稳定性,促进内皮细胞炎症和细胞焦亡,加重动脉粥样硬化。
FASEB J. 2024 Oct 31;38(20):e70090. doi: 10.1096/fj.202401337RR.
3
METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.METTL14 通过调控 M6A 甲基化修饰的初级 miR-19a 促进心血管内皮细胞的增殖和侵袭。
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):7015-7023. doi: 10.26355/eurrev_202006_21694.
4
METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.METTL14 通过增加 FOXO1 N6-甲基腺苷修饰加剧内皮炎症和动脉粥样硬化。
Theranostics. 2020 Jul 11;10(20):8939-8956. doi: 10.7150/thno.45178. eCollection 2020.
5
Methyltransferase-like 14 promotes ferroptosis in sepsis-induced acute kidney injury via increasing the m6A methylation modification of LPCAT3.类甲基转移酶14通过增加溶血磷脂酰胆碱酰基转移酶3的m6A甲基化修饰促进脓毒症诱导的急性肾损伤中的铁死亡。
Mol Genet Genomics. 2025 Jan 21;300(1):16. doi: 10.1007/s00438-024-02219-1.
6
METTL14-mediated m6A methylation regulates pathological retinal neovascularization by targeting autophagy.METTL14 通过靶向自噬调节 m6A 甲基化调控病理性视网膜新生血管形成。
Exp Cell Res. 2024 Nov 1;443(1):114291. doi: 10.1016/j.yexcr.2024.114291. Epub 2024 Oct 24.
7
METTL14-Mediated m6A Modification of Represses Ferroptosis in Alzheimer's Disease via Inhibiting GDF15 Ubiquitination.METTL14 介导的 m6A 修饰通过抑制 GDF15 泛素化抑制阿尔茨海默病中的铁死亡。
Front Biosci (Landmark Ed). 2024 Aug 21;29(8):298. doi: 10.31083/j.fbl2908298.
8
METTL14 promotes chondrocyte ferroptosis in osteoarthritis via m6A modification of GPX4.METTL14 通过调控 GPX4 的 m6A 修饰促进骨关节炎软骨细胞铁死亡。
Int J Rheum Dis. 2024 Aug;27(8):e15297. doi: 10.1111/1756-185X.15297.
9
METTL14 modulates the progression and ferroptosis of colitis by regulating the stability of m6A-modified GPX4.METTL14通过调节m6A修饰的GPX4的稳定性来调控结肠炎的进展和铁死亡。
Eur J Med Res. 2025 Feb 8;30(1):88. doi: 10.1186/s40001-025-02334-8.
10
METTL14 downregulates GLUT9 through m6A methylation and attenuates hyperuricemia-induced fibrosis in mouse renal tubular epithelial cells.METTL14 通过 m6A 甲基化下调 GLUT9,减轻高尿酸血症诱导的小鼠肾小管上皮细胞纤维化。
Int Immunopharmacol. 2024 Dec 25;143(Pt 1):113308. doi: 10.1016/j.intimp.2024.113308. Epub 2024 Oct 10.

引用本文的文献

1
SPTBN1 overexpression ameliorates atherosclerosis by inhibiting oxidative stress and inflammation via regulating the TRIM37/TRAF2/NF-κB pathway.SPTBN1过表达通过调节TRIM37/TRAF2/NF-κB途径抑制氧化应激和炎症来改善动脉粥样硬化。
Eur J Med Res. 2025 Aug 21;30(1):781. doi: 10.1186/s40001-025-02994-6.
2
m6A modification of non‑coding RNA: Mechanisms, functions and potential values in human diseases (Review).非编码RNA的m6A修饰:机制、功能及在人类疾病中的潜在价值(综述)
Int J Mol Med. 2025 Oct;56(4). doi: 10.3892/ijmm.2025.5605. Epub 2025 Aug 8.